DXP Enterprises Q3 2026 Earnings: Pumping Solutions Leads 14.3% Sales Growth

DXP Enterprises (NASDAQ: DXPE) reported Q3 2026 sales of $587.2 million for the quarter ended September 30, 2026, up 14.3% from $513.7 million, while GAAP diluted EPS rose to $1.64 from $1.31. Net income and adjusted EBITDA grew faster than sales, but quarterly free cash flow declined despite the stronger earnings.

Core Financial Results

Growth came from both existing operations and acquisitions. Organic sales increased approximately 8.7% to $538.3 million from $495.3 million, while businesses owned for less than 12 months contributed $48.8 million, or about 8.3% of total quarterly sales.

Adjusted EBITDA rose 19.0%, and its margin expanded by 50 basis points. Operating income also outpaced revenue growth, although gross margin declined and quarterly cash generation weakened.

Adjusted EBITDA and free cash flow are non-GAAP measures. Gross margins and certain percentage changes are approximate calculations based on the reported figures.

Business and Segment Performance

Innovative Pumping Solutions was the main growth engine, accounting for approximately $43.6 million of DXP’s $73.5 million increase in quarterly sales. Service Centers remained the largest business, while Supply Chain Services posted more modest revenue growth.

Innovative Pumping Solutions’ operating income increased approximately 27.4%, slower than its revenue growth, and its operating margin declined from about 18.3% to 16.3%. Service Centers’ margin was nearly unchanged, while Supply Chain Services expanded its margin from approximately 8.4% to 9.0%.

Operating Leverage Offset Gross-Margin Pressure, but Quarterly Cash Conversion Weakened

DXP’s gross margin declined by approximately 70 basis points, but selling, general and administrative expenses increased only 8.9%, slower than revenue. As a percentage of sales, SG&A fell to about 21.8% from 22.9%, helping operating margin rise to 8.9%. Corporate expenses were also nearly flat at $25.7 million, compared with $26.0 million a year earlier.

Cash flow moved in the opposite direction from earnings during the quarter. Operating cash flow fell to $18.7 million from $34.9 million, and free cash flow declined to $14.4 million from $28.1 million. The nine-month figures were more favorable: operating cash flow reached $80.6 million versus $56.5 million, while lower capital spending helped nine-month free cash flow rise to $70.5 million from $19.5 million.

DXP ended September with $218.8 million in cash, down from $303.8 million at the end of 2025. Total debt outstanding was $839.5 million, and management reported a secured net-debt-to-EBITDA ratio of 2.30 times, based on $270.0 million of covenant EBITDA for the trailing 12 months. Accounts receivable and inventory also increased from year-end levels, making working-capital conversion an important area to monitor.

Management Commentary

Chairman and CEO David R. Little attributed the quarter’s growth to a combination of organic performance and recent acquisitions. Management’s priorities remain integrating acquired businesses, pursuing additional acquisitions, generating cash flow, and positioning DXP for continued growth in 2027.

CFO Kent Yee noted that DXP had completed five acquisitions through the third quarter. He also emphasized the company’s business mix and balance-sheet capacity while expressing confidence in its momentum entering fiscal 2027.

Recent Insider Transactions

The six-month insider summary showed 53,592 shares purchased across six transactions and 17,942 shares sold across three transactions, resulting in net purchases of 35,650 shares. The separate recent-report list below includes stock grants and gifts as well as sales, so those awards should not be treated as equivalent to open-market purchases.

These transactions describe reported activity but do not, by themselves, establish insiders’ views of DXP’s valuation or outlook.

Risks for Investors to Watch

• Acquisition integration and leverage: Acquisition sales contributed $48.8 million, and DXP completed five acquisitions through Q3. Integration execution is increasingly important with $839.5 million of debt outstanding.
• Quarterly cash conversion: Operating cash flow and free cash flow fell sharply even as net income increased. Sustained weakness would reduce internally generated funds available for acquisitions and debt repayment.
• Segment margin mix: Innovative Pumping Solutions led revenue growth, but its operating margin declined by approximately two percentage points. Continued growth at a lower margin could limit consolidated margin expansion.
• Interest burden: Quarterly interest expense increased to $16.9 million from $14.9 million, absorbing part of the improvement in operating profit.

Summary

DXP’s Q3 2026 results combined double-digit sales growth with faster increases in operating income, net income, and adjusted EBITDA. Innovative Pumping Solutions and acquired businesses were the main growth contributors, while SG&A leverage offset a lower gross margin. The main follow-up issues are quarterly cash conversion, Pumping Solutions’ margin trajectory, and DXP’s ability to integrate acquisitions while managing leverage.